It was a massive turnout for the PEACE-Hepatitis SA World Hepatitis Day 2015 Lunch. More than 150 community members attended the lunch which was also mega workshop on hepatitis B.
Leaders of key South Australian Chinese organisations have called for urgent action to increase diagnosis, management and treatment of hepatitis B in their community.
People living with hepatitis B are now able to get their medicine from any pharmacy, regardless of whether the medicine has been prescribed in a hospital or community setting. They will no longer need to travel to hospital-based pharmacies for their prescriptions to be filled.
The Parliamentary Inquiry into Hepatitis C in Australia has tabled its report making 10 recommendations including the setting of targets for testing and treatment.
AbbVie reports a 100% response rate to Viekira Pak as a standalone treatment after 12 weeks in a late-stage study.
People with hepatitis C who shared their stories in a new book, have called for new treatments to be made available.
Information on clinical trials in Australia are now just a few keystrokes away.
The Pharmaceutical Benefits Advisory Committee (PBAC) is to consider further new hepatitis C medicines at its July 2015 meeting.
Importing medicines to treat your hepatitis C is an option full of pitfalls.
The Therapeutic Goods Administration (TGA) has approved ledipasvir/sofosbuvir (commercial name, Harvoni) for use in treating hepatitis C.
